The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico

Citation:
Elfiky, A. A., E. B. Azzam, and M. W. Shafaa, "The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico", Molecular Diversity, vol. 26, issue 1, pp. 171 - 181, 2022.

Abstract:

n/a

Notes:

Cited By :8Export Date: 7 May 2022

Related External Link

Tourism